561 related articles for article (PubMed ID: 26386135)
1. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders.
Heyes S; Pratt WS; Rees E; Dahimene S; Ferron L; Owen MJ; Dolphin AC
Prog Neurobiol; 2015 Nov; 134():36-54. PubMed ID: 26386135
[TBL] [Abstract][Full Text] [Related]
2. Genetic Associations between Voltage-Gated Calcium Channels and Psychiatric Disorders.
Andrade A; Brennecke A; Mallat S; Brown J; Gomez-Rivadeneira J; Czepiel N; Londrigan L
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331039
[TBL] [Abstract][Full Text] [Related]
3. Targeting voltage-gated calcium channels in neurological and psychiatric diseases.
Zamponi GW
Nat Rev Drug Discov; 2016 Jan; 15(1):19-34. PubMed ID: 26542451
[TBL] [Abstract][Full Text] [Related]
4. Voltage-gated calcium channel blockers for psychiatric disorders: genomic reappraisal.
Harrison PJ; Tunbridge EM; Dolphin AC; Hall J
Br J Psychiatry; 2020 May; 216(5):250-253. PubMed ID: 31230606
[TBL] [Abstract][Full Text] [Related]
5. Voltage-gated Calcium Channels and Autism Spectrum Disorders.
Breitenkamp AF; Matthes J; Herzig S
Curr Mol Pharmacol; 2015; 8(2):123-32. PubMed ID: 25966693
[TBL] [Abstract][Full Text] [Related]
6. Small Molecules as Modulators of Voltage-Gated Calcium Channels in Neurological Disorders: State of the Art and Perspectives.
Lanzetti S; Di Biase V
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209100
[TBL] [Abstract][Full Text] [Related]
7. Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders.
Lory P; Mezghrani A
IDrugs; 2010 Jul; 13(7):467-71. PubMed ID: 20582871
[TBL] [Abstract][Full Text] [Related]
8. Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease.
Nanou E; Catterall WA
Neuron; 2018 May; 98(3):466-481. PubMed ID: 29723500
[TBL] [Abstract][Full Text] [Related]
9. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.
Gandal MJ; Haney JR; Parikshak NN; Leppa V; Ramaswami G; Hartl C; Schork AJ; Appadurai V; Buil A; Werge TM; Liu C; White KP; ; ; ; Horvath S; Geschwind DH
Science; 2018 Feb; 359(6376):693-697. PubMed ID: 29439242
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms and their characterization with oligonucleotide microarrays.
Dalma-Weiszhausz DD; Murphy GM
Psychiatr Genet; 2002 Jun; 12(2):97-107. PubMed ID: 12131762
[TBL] [Abstract][Full Text] [Related]
11. L-type calcium channels and psychiatric disorders: A brief review.
Casamassima F; Hay AC; Benedetti A; Lattanzi L; Cassano GB; Perlis RH
Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1373-90. PubMed ID: 20886543
[TBL] [Abstract][Full Text] [Related]
12. Ion channel mutations in mouse models of inherited neurological disease.
Meisler MH; Sprunger LK; Plummer NW; Escayg A; Jones JM
Ann Med; 1997 Dec; 29(6):569-74. PubMed ID: 9562526
[TBL] [Abstract][Full Text] [Related]
13. NMDA receptor subunit mutations in neurodevelopmental disorders.
Burnashev N; Szepetowski P
Curr Opin Pharmacol; 2015 Feb; 20():73-82. PubMed ID: 25498981
[TBL] [Abstract][Full Text] [Related]
14. Voltage-dependent calcium channel mutations in neurological disease.
Burgess DL; Noebels JL
Ann N Y Acad Sci; 1999 Apr; 868():199-212. PubMed ID: 10414295
[TBL] [Abstract][Full Text] [Related]
15. Protein complexes as psychiatric and neurological drug targets.
Kato AS; Witkin JM
Biochem Pharmacol; 2018 May; 151():263-281. PubMed ID: 29330067
[TBL] [Abstract][Full Text] [Related]
16. [Auto-immune disorders as a possible cause of neuropsychiatric syndromes].
Martinez-Martinez P; Molenaar PC; Losen M; Hoffmann C; Stevens J; de Witte LD; van Amelsvoort T; van Os J; Rutten BP
Tijdschr Psychiatr; 2015; 57(3):183-91. PubMed ID: 25856741
[TBL] [Abstract][Full Text] [Related]
17. Calcium channelopathies.
Lorenzon NM; Beam KG
Kidney Int; 2000 Mar; 57(3):794-802. PubMed ID: 10720931
[TBL] [Abstract][Full Text] [Related]
18. Sodium channel mutations in epilepsy and other neurological disorders.
Meisler MH; Kearney JA
J Clin Invest; 2005 Aug; 115(8):2010-7. PubMed ID: 16075041
[TBL] [Abstract][Full Text] [Related]
19. Modulators of voltage-dependent calcium channels for the treatment of nervous system diseases.
Takahashi E; Niimi K
Recent Pat CNS Drug Discov; 2009 Jun; 4(2):96-111. PubMed ID: 19519559
[TBL] [Abstract][Full Text] [Related]
20. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
Cross-Disorder Group of the Psychiatric Genomics Consortium
Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
